LIMK1 and breast cancer: miR-654-5p mimics reduced the expression of LIMK1 in Hs578T and PL-BC-05 cells, while a miR-654-5p inhibitor enhanced LIMK1 levels in MCF-7 cells (Figs. 3G, H and S3D).